procaterol has been researched along with oxitropium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, J; Kamei, T; Kishimoto, N; Kobayashi, M; Ohnishi, H; Tada, S; Ueda, N; Yamasaki, Y | 1 |
| Honma, M; Sano, MA; Satake, M; Sato, K; Shioya, T; Sugawara, K; Takahashi, H | 1 |
1 trial(s) available for procaterol and oxitropium
| Article | Year |
|---|---|
Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities
Topics: Activities of Daily Living; Adrenergic beta-Agonists; Aged; Exercise; Exercise Test; Female; Forced Expiratory Volume; Humans; Male; Parasympatholytics; Procaterol; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Scopolamine Derivatives; Spirometry; Surveys and Questionnaires | 2008 |
1 other study(ies) available for procaterol and oxitropium
| Article | Year |
|---|---|
[Beta 2-adrenoceptor polymorphism and effects of inhaled beta 2-stimulant (procaterol) and an anti-cholinergic drug (oxitropium) on the airway resistance].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Airway Resistance; Alleles; Cholinergic Antagonists; Codon; Female; Humans; Polymorphism, Genetic; Procaterol; Receptors, Adrenergic, beta-2; Scopolamine Derivatives | 2004 |